SHL Telemedicine Ltd. (SIX: SHLTN.SW) Stock Competitors & Peer Comparison
See SHLTN.SW's competitors and their performance on the SIX and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for SHLTN.SW and its SIX peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SHLTN.SW | CHF 1.07 | +0.00% | 39.7M | -0.62 | -CHF 1.71 | N/A |
| ABT.SW | CHF 72.50 | -2.68% | 125.5B | 19.79 | CHF 3.66 | +2.78% |
| SOON.SW | CHF 283.20 | +2.31% | 16.7B | 30.88 | CHF 9.10 | +1.67% |
| ZBH.SW | CHF 75.00 | -3.23% | 14.5B | 12.13 | CHF 6.19 | +1.04% |
| MED.SW | CHF 94.20 | +4.55% | 1.1B | 76.42 | CHF 1.20 | N/A |
| KURN.SW | CHF 20.30 | +4.42% | 807.7M | 112.49 | CHF 0.18 | N/A |
| METN.SW | CHF 838.00 | -1.64% | 375.4M | -34.83 | -CHF 24.06 | N/A |
Stock Comparison
Abbott Laboratories (SIX: ABT.SW)
SHLTN.SW vs ABT.SW Comparison October 2026
SHL Telemedicine Ltd. (SIX: SHLTN.SW) plays a significant role within the Healthcare sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHLTN.SW stands at 39.7M. In comparison, ABT.SW has a market cap of 125.5B. Regarding current trading prices, SHLTN.SW is priced at CHF 1.07 on the SIX, while ABT.SW trades at CHF 72.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHLTN.SW currently has a P/E ratio of -0.62, whereas ABT.SW's P/E ratio is 19.79. In terms of profitability, SHLTN.SW's ROE is -0.34%, compared to ABT.SW's ROE of +0.09%. Regarding short-term risk, SHLTN.SW is similarly volatile compared to ABT.SW. This indicates similar risk in terms of short-term price fluctuations for SHLTN.SW.Check ABT.SW's competition here